Top Markets
Coin of the day
Caliber Imaging & Diagnostics, Inc. Caliber Imaging & Diagnostics, Inc.

Caliber Imaging & Diagnostics, Inc.

LCDX
Rang in Aktien #42076
Caliber Imaging & Diagnostics, Inc. is a U.S.-based medical technology firm... Caliber Imaging & Diagnostics, Inc. is a U.S.-based medical technology firm that develops, manufactures, and markets advanced imaging solutions designed to visualize tissue at a cellular resolution. Their product line features the VivaScope 1500, a reflectance confocal imaging system that empowers medical practitioners and scientists to capture detailed confocal images depicting the cellular architecture of living tissue. They also provide the VivaScope 3000, a handheld in vivo reflectance confocal microscope tailored for dermatological imaging. Complementing its hardware, the firm offers VivaScan software, which streamlines patient scheduling, facilitates multi-lesion imaging during appointments, and assists with image review and reporting. Additionally, they supply VivaNet, a sophisticated digital telepathology system. Initially established as Lucid, Inc. in 1991, the company rebranded as Caliber Imaging & Diagnostics, Inc. in August 2012 and is headquartered in Andover, Massachusetts.
Aktienkurs
$0.0006
Zuletzt synchronisiert: 2026-08-11
Marktkapitalisierung
$5.10K
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
500.00%
Land
US
Handel Caliber Imaging & Diagnostics, Inc. (LCDX)

Kategorie

EPS für Caliber Imaging & Diagnostics, Inc. (LCDX)
EPS zum 2026 TTM: 0
Laut den aktuellen Finanzberichten und dem Aktienkurs von Caliber Imaging & Diagnostics, Inc. beträgt das aktuelle EPS des Unternehmens (TTM) 0. Am Ende des Jahres 2026 betrug das EPS 0 gleich wie dem EPS von 2026, das 0 betrug.
EPS-Verlauf von Caliber Imaging & Diagnostics, Inc. von 2026 bis 2026
EPS am Ende jedes Jahres
Jahr EPS ändert
Nicht genügend Daten für die angegebenen Daten.
EPS für ähnliche Unternehmen oder Wettbewerber